Q-omics provides the consensus-scored MIR362 profile across patient tissues and cancer cell-line models. MIR362 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, MIR362 RNA expression shows 6,537 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight TGCT, and UCEC as cancer lineages where MIR362 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.